突触囊泡内分细胞缺陷是帕金森病和患有勒维体痴呆症的GBA相关认知功能障碍的基础
D J Vidyadhara1,2,3,4, David Bäckström1,2,5, Risha Chakraborty1,2
1Department of Neurology, Yale University, CT, USA.
bioRxiv : the preprint server for biology
|November 1, 2024
概括
葡萄糖脑糖酶 (GBA) 突变会导致帕金森病 (PD) 和患有勒维体痴呆症 (DLB) 的认知缺陷,因为它会损害独立于α-synuclein的突触囊内细胞酶.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- GBA基因是帕金森病 (PD) 和患有勒维体痴呆症 (DLB) 的主要危险因素.
- 在这些α-synucleinopathies中,认知缺陷很常见.
- 在认知衰退中GBA突变的确切作用尚不清楚.
研究的目的:
- 研究GBA突变对认知功能和潜在机制的影响.
- 为了区分GBA突变与认知衰退中的α-synuclein病理学的影响.
- 探索突触囊泡内细胞在GBA相关认知缺陷中的作用.
主要方法:
- 使用了Gbe (L444P) 突变小鼠,SNCA转基因小鼠和Gbe-SNCA双突变小鼠.
- 在小鼠模型中评估认知和运动缺陷.
- 在小鼠皮层上进行了单核RNA测序,免疫组织化学和电子显微镜.
主要成果:
- GBA突变小鼠表现出早期的认知缺陷,但没有运动缺陷或α-synuclein病理.
- 转基因SNCA小鼠表现出运动缺陷而没有认知异常.
- 格巴-SNCA小鼠表现出认知衰退和加剧的运动缺陷,皮质酸-α-synuclein增加.
- 在Gba突变和Gba-SNCA小鼠皮层中观察到突触囊泡内分细胞缺陷和相关基因的下调.
结论:
- 通过α-synuclein独立的机制,GBA突变有助于认知缺陷.
- 突触囊泡内分泌的功能障碍与GBA相关的认知衰退有关.
- 在PD/DLB模型中,GBA突变加剧了α-synuclein聚合和运动缺陷.
关键词:
认知功能障碍 认知功能障碍痴呆症与利维体的痴呆症.在GBA中,GBA是GBA.莱维体痴呆症 (Lewy体痴呆症) 是一种疾病.帕金森病是帕金森氏症的一种疾病.帕金森氏症与痴呆症相关的疾病.这是SNCA的SNCA.这就是 snRNA-seqq.突触性可塑性 突触性可塑性突触囊泡内细胞结合症是什么α-synuclein 是一种同核蛋白.α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies,即α-synucleinopathies.相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Treatment
224
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
224


